Variant report
Variant | esv2634712 |
---|---|
Chromosome Location | chr6:28189671-28191361 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:61)
- Chromatin interactive region (count:43)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:28189508-28189708 | IMR90 | lung: | n/a | chr6:28189578-28189589 |
2 | CEBPB | chr6:28189438-28189840 | K562 | blood: | n/a | chr6:28189578-28189589 |
3 | CEBPB | chr6:28189473-28189868 | HepG2 | liver: | n/a | chr6:28189578-28189589 |
4 | EP300 | chr6:28189822-28190209 | K562 | blood: | n/a | n/a |
5 | JUN | chr6:28190034-28190223 | K562 | blood: | n/a | n/a |
6 | JUN | chr6:28189993-28190038 | HepG2 | liver: | n/a | n/a |
7 | JUND | chr6:28189530-28190289 | K562 | blood: | n/a | n/a |
8 | MAFF | chr6:28189685-28189885 | HepG2 | liver: | n/a | chr6:28189718-28189736 |
9 | MAFK | chr6:28189610-28189863 | HepG2 | liver: | n/a | chr6:28189721-28189732 |
10 | POLR2A | chr6:28189386-28190282 | K562 | blood: | n/a | n/a |
11 | STAT3 | chr6:28190664-28190783 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | YY1 | chr6:28189597-28189810 | K562 | blood: | n/a | n/a |
13 | ZNF384 | chr6:28189996-28190324 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:28190810-28190860 | SK-N-MC | brain: | n/a |
2 | chr6:28190810-28190860 | HCT-116 | colon: | n/a |
3 | chr6:28190810-28190860 | Hela-S3 | cervix: | n/a |
4 | chr6:28190810-28190860 | IMR90 | lung: | fetal |
5 | chr6:28190810-28190860 | SKMC | muscle: | n/a |
6 | chr6:28190810-28190860 | AG04449 | skin: | fetal |
7 | chr6:28190810-28190860 | HEK293 | kidney: | embryo |
8 | chr6:28190810-28190860 | AoSMC | blood vessel: | n/a |
9 | chr6:28190810-28190860 | HNPCEpiC | eye: | n/a |
10 | chr6:28190810-28190860 | HRE | kidney: | n/a |
11 | chr6:28190810-28190860 | HRPEpiC | eye: | n/a |
12 | chr6:28190810-28190860 | CMK | blood: | n/a |
13 | chr6:28190810-28190860 | ovcar-3 | ovarian: | n/a |
14 | chr6:28190810-28190860 | HCM | heart: | n/a |
15 | chr6:28190810-28190860 | RPTEC | kidney: | n/a |
16 | chr6:28190810-28190860 | PANC-1 | pancreas: | n/a |
17 | chr6:28190810-28190860 | GM19239 | blood: | n/a |
18 | chr6:28190810-28190860 | SAEC | small airway: | n/a |
19 | chr6:28190810-28190860 | ProgFib | skin: | n/a |
20 | chr6:28190810-28190860 | BE2_C | brain: | n/a |
21 | chr6:28190810-28190860 | ECC-1 | luminal epithelium: | n/a |
22 | chr6:28190810-28190860 | HCPEpiC | choroid plexus: | n/a |
23 | chr6:28190810-28190860 | HRCEpiC | kidney: | n/a |
24 | chr6:28190810-28190860 | SK-N-SH_RA | brain: | n/a |
25 | chr6:28190810-28190860 | NHDF-neo | bronchial: | n/a |
26 | chr6:28190810-28190860 | Caco-2 | colon: | n/a |
27 | chr6:28190810-28190860 | HL-60 | blood: | n/a |
28 | chr6:28190810-28190860 | BJ | skin: | n/a |
29 | chr6:28190810-28190860 | GM06990 | blood: | n/a |
30 | chr6:28190810-28190860 | AG04450 | lung: | fetal |
31 | chr6:28190810-28190860 | SK-N-SH | brain: | n/a |
32 | chr6:28190810-28190860 | LNCaP | prostate: | n/a |
33 | chr6:28190810-28190860 | GM12891 | blood: | n/a |
34 | chr6:28190810-28190860 | K562 | blood: | n/a |
35 | chr6:28190810-28190860 | GM12878 | blood: | n/a |
36 | chr6:28190810-28190860 | NT2-D1 | testis: | n/a |
37 | chr6:28190810-28190860 | T-47D | breast: | n/a |
38 | chr6:28190810-28190860 | PFSK-1 | brain: | n/a |
39 | chr6:28190810-28190860 | GM12892 | blood: | n/a |
40 | chr6:28190810-28190860 | A549 | lung: | n/a |
41 | chr6:28190810-28190860 | AG10803 | skin: | n/a |
42 | chr6:28190810-28190860 | MCF-7 | breast: | n/a |
43 | chr6:28190810-28190860 | Hepatocyte | liver: | n/a |
44 | chr6:28190810-28190860 | H1-hESC | embryonic stem cell: | embryo |
45 | chr6:28190810-28190860 | HUVEC | blood vessel: | n/a |
46 | chr6:28190810-28190860 | HIPEpiC | eye: | n/a |
47 | chr6:28190810-28190860 | HCF | heart: | n/a |
48 | chr6:28190810-28190860 | HMEC | breast: | n/a |
49 | chr6:28190810-28190860 | HepG2 | liver: | n/a |
50 | chr6:28190810-28190860 | HEEpiC | esophagus: | n/a |
(count:43 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:28187353..28190192-chr6:28583076..28585455,2 | K562 | blood: | |
2 | chr6:28188391..28191172-chr6:28347437..28349201,2 | K562 | blood: | |
3 | chr6:28184339..28187958-chr6:28190844..28194750,7 | MCF-7 | breast: | |
4 | chr6:28188437..28190413-chr6:28337561..28339400,2 | K562 | blood: | |
5 | chr6:28100317..28107200-chr6:28184436..28191088,8 | MCF-7 | breast: | |
6 | chr6:28108043..28113786-chr6:28190485..28194607,10 | K562 | blood: | |
7 | chr6:28188764..28191744-chr6:28301995..28304592,2 | MCF-7 | breast: | |
8 | chr6:28047206..28049069-chr6:28188430..28191262,2 | K562 | blood: | |
9 | chr6:28102806..28106129-chr6:28190797..28194598,4 | K562 | blood: | |
10 | chr6:28183629..28195178-chr6:28316250..28325659,29 | K562 | blood: | |
11 | chr6:28135337..28137302-chr6:28186822..28190274,4 | K562 | blood: | |
12 | chr6:28186877..28189778-chr6:28366321..28368559,2 | K562 | blood: | |
13 | chr6:28188896..28191056-chr6:28251556..28253787,2 | K562 | blood: | |
14 | chr6:28187375..28189818-chr6:28709219..28712133,2 | K562 | blood: | |
15 | chr6:27775362..27779371-chr6:28186093..28189957,4 | K562 | blood: | |
16 | chr6:27834531..27836106-chr6:28188635..28190287,2 | K562 | blood: | |
17 | chr6:28103775..28113920-chr6:28177995..28190115,32 | K562 | blood: | |
18 | chr6:28187359..28189911-chr6:28455377..28457870,2 | K562 | blood: | |
19 | chr6:28081584..28085062-chr6:28187366..28190014,3 | K562 | blood: | |
20 | chr6:28163458..28166230-chr6:28188324..28191413,3 | K562 | blood: | |
21 | chr6:28184981..28190782-chr6:28297491..28307222,23 | K562 | blood: | |
22 | chr6:28182735..28195387-chr6:28315960..28325841,32 | K562 | blood: | |
23 | chr6:28184789..28191313-chr6:28230652..28235913,7 | K562 | blood: | |
24 | chr6:28130769..28134274-chr6:28187281..28190236,3 | K562 | blood: | |
25 | chr6:28153153..28155076-chr6:28188462..28190523,2 | K562 | blood: | |
26 | chr6:28190987..28192829-chr6:28194559..28196499,2 | MCF-7 | breast: | |
27 | chr6:28087049..28089835-chr6:28187380..28190025,2 | K562 | blood: | |
28 | chr6:28186460..28191177-chr6:28246836..28252039,7 | K562 | blood: | |
29 | chr6:28017721..28019447-chr6:28188224..28189953,2 | K562 | blood: | |
30 | chr6:27857437..27861183-chr6:28187100..28189751,4 | K562 | blood: | |
31 | chr6:28182366..28191375-chr6:28300021..28306741,17 | K562 | blood: | |
32 | chr6:28187110..28190886-chr6:28224658..28229038,5 | K562 | blood: | |
33 | chr6:27834298..27836031-chr6:28187958..28190135,2 | K562 | blood: | |
34 | chr6:28188045..28189911-chr6:28456370..28458760,2 | K562 | blood: | |
35 | chr6:27856777..27859583-chr6:28186890..28189718,3 | K562 | blood: | |
36 | chr6:28102723..28113786-chr6:28183725..28194756,41 | K562 | blood: | |
37 | chr6:28189695..28192033-chr6:28349571..28352462,4 | K562 | blood: | |
38 | chr6:28114623..28117122-chr6:28187567..28190304,2 | K562 | blood: | |
39 | chr6:28184931..28189194-chr6:28190077..28194573,12 | MCF-7 | breast: | |
40 | chr6:28127881..28130043-chr6:28189652..28192231,2 | K562 | blood: | |
41 | chr6:27860430..27862717-chr6:28186992..28190210,3 | K562 | blood: | |
42 | chr6:28083562..28085258-chr6:28187886..28189759,2 | K562 | blood: | |
43 | chr6:28188183..28189832-chr6:28247403..28249433,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TOB2P1 | TF binding region |
ZSCAN9 | TF binding region |
TOB2P1 | CpG island |
ZSCAN9 | CpG island |
ENSG00000196331 | chromatin interactions |
ENSG00000197153 | chromatin interactions |
ENSG00000137185 | chromatin interactions |
ENSG00000137338 | chromatin interactions |
ENSG00000176933 | chromatin interactions |
ENSG00000198315 | chromatin interactions |
ENSG00000272009 | chromatin interactions |
ENSG00000219392 | chromatin interactions |
ENSG00000269293 | chromatin interactions |
ENSG00000187626 | chromatin interactions |
ENSG00000232040 | chromatin interactions |
ENSG00000196747 | chromatin interactions |
ENSG00000203813 | chromatin interactions |
ENSG00000185130 | chromatin interactions |
ENSG00000184357 | chromatin interactions |
ENSG00000235109 | chromatin interactions |
ENSG00000197062 | chromatin interactions |
ENSG00000197279 | chromatin interactions |
ENSG00000189134 | chromatin interactions |
ENSG00000233224 | chromatin interactions |
ENSG00000226314 | chromatin interactions |
ENSG00000261839 | chromatin interactions |
ENSG00000158691 | chromatin interactions |
ENSG00000189298 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558848448 | chr6:28189691-28189692 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 24 gene(s) | Overlapped CNVs | n/a |
2 | rs143877888 | chr6:28189816-28189817 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 23 gene(s) | Overlapped CNVs | n/a |
3 | rs12211150 | chr6:28189907-28189908 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 23 gene(s) | Overlapped CNVs | n/a |
4 | rs113358235 | chr6:28189913-28189914 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 23 gene(s) | Overlapped CNVs | n/a |
5 | rs543421394 | chr6:28189960-28189961 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 20 gene(s) | Overlapped CNVs | n/a |
6 | rs557299269 | chr6:28189962-28189963 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 20 gene(s) | Overlapped CNVs | n/a |
7 | rs190211261 | chr6:28190078-28190079 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 20 gene(s) | Overlapped CNVs | n/a |
8 | rs12211259 | chr6:28190086-28190087 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 20 gene(s) | Overlapped CNVs | n/a |
9 | rs183456507 | chr6:28190102-28190103 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 20 gene(s) | Overlapped CNVs | n/a |
10 | rs559525252 | chr6:28190123-28190124 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 20 gene(s) | Overlapped CNVs | n/a |
11 | rs540882978 | chr6:28190128-28190129 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 20 gene(s) | Overlapped CNVs | n/a |
12 | rs12211332 | chr6:28190163-28190164 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 20 gene(s) | Overlapped CNVs | n/a |
13 | rs377406468 | chr6:28190208-28190209 | Weak transcription | TF binding regionChromatin interactive region | 19 gene(s) | Overlapped CNVs | n/a |
14 | rs371146238 | chr6:28190209-28190210 | Weak transcription | TF binding regionChromatin interactive region | 19 gene(s) | Overlapped CNVs | n/a |
15 | rs374652853 | chr6:28190212-28190213 | Weak transcription | TF binding regionChromatin interactive region | 16 gene(s) | Overlapped CNVs | n/a |
16 | rs12211438 | chr6:28190247-28190248 | Weak transcription | TF binding regionChromatin interactive region | 16 gene(s) | Overlapped CNVs | n/a |
17 | rs528624217 | chr6:28190348-28190349 | Weak transcription | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
18 | rs545311613 | chr6:28190424-28190425 | Weak transcription Enhancers | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
19 | rs199592243 | chr6:28190532-28190533 | Weak transcription Enhancers | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
20 | rs553090114 | chr6:28190579-28190580 | Weak transcription Enhancers | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
21 | rs565412777 | chr6:28190591-28190592 | Weak transcription Enhancers | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
22 | rs531214884 | chr6:28190661-28190662 | Weak transcription Enhancers | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
23 | rs550340616 | chr6:28190662-28190663 | Weak transcription Enhancers | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
24 | rs567243669 | chr6:28190663-28190664 | Weak transcription Enhancers | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
25 | rs529797614 | chr6:28190670-28190671 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 15 gene(s) | Overlapped CNVs | n/a |
26 | rs144532805 | chr6:28190715-28190716 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 15 gene(s) | Overlapped CNVs | n/a |
27 | rs566680745 | chr6:28190721-28190722 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 15 gene(s) | Overlapped CNVs | n/a |
28 | rs538801265 | chr6:28190794-28190795 | Weak transcription Enhancers | Chromatin interactive region | 13 gene(s) | Overlapped CNVs | n/a |
29 | rs558912135 | chr6:28190810-28190811 | Weak transcription Enhancers | CpG islandChromatin interactive region | 15 gene(s) | Overlapped CNVs | n/a |
30 | rs569081472 | chr6:28190814-28190815 | Weak transcription Enhancers | CpG islandChromatin interactive region | 15 gene(s) | Overlapped CNVs | n/a |
31 | rs9393908 | chr6:28190830-28190831 | Weak transcription Enhancers | CpG islandChromatin interactive region | 15 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs557125051 | chr6:28190844-28190845 | Weak transcription Enhancers | CpG islandChromatin interactive region | 15 gene(s) | Overlapped CNVs | n/a |
33 | rs550662708 | chr6:28190907-28190908 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
34 | rs199758214 | chr6:28190908-28190909 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
35 | rs376633223 | chr6:28190910-28190911 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
36 | rs118167068 | chr6:28190919-28190920 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
37 | rs542189356 | chr6:28190925-28190926 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
38 | rs534388143 | chr6:28190933-28190934 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
39 | rs563562772 | chr6:28190939-28190940 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
40 | rs546616195 | chr6:28190966-28190967 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
41 | rs555161514 | chr6:28190997-28190998 | Weak transcription Enhancers | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
42 | rs185872392 | chr6:28191006-28191007 | Weak transcription Enhancers | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
43 | rs191171856 | chr6:28191012-28191013 | Weak transcription Enhancers | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
44 | rs9366717 | chr6:28191057-28191058 | Weak transcription Enhancers | Chromatin interactive region | 12 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs146147105 | chr6:28191064-28191065 | Weak transcription Enhancers | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
46 | rs182638892 | chr6:28191077-28191078 | Weak transcription Enhancers | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
47 | rs187646918 | chr6:28191100-28191101 | Weak transcription Enhancers | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
48 | rs192521524 | chr6:28191161-28191162 | Weak transcription Enhancers | Chromatin interactive region | 12 gene(s) | Overlapped CNVs | n/a |
49 | rs182845469 | chr6:28191194-28191195 | Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
50 | rs558192423 | chr6:28191226-28191227 | Bivalent/Poised TSS Weak transcription Enhancers | Chromatin interactive region | 11 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Bipolar disorder | 19114987 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:28186600-28192400 | Weak transcription | Spleen | Spleen |
2 | chr6:28187000-28192400 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr6:28187000-28192400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr6:28187200-28189800 | Weak transcription | NHEK | skin |
5 | chr6:28187200-28190800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr6:28187200-28192000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr6:28187200-28192000 | Weak transcription | HMEC | breast |
8 | chr6:28187200-28192200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr6:28187400-28192000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
10 | chr6:28187400-28192000 | Weak transcription | Hela-S3 | cervix |
11 | chr6:28188200-28191200 | Weak transcription | Placenta | Placenta |
12 | chr6:28188600-28192400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr6:28188800-28192000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
14 | chr6:28188800-28192000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr6:28189000-28190200 | Enhancers | K562 | blood |
16 | chr6:28189400-28190000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr6:28189800-28190000 | Enhancers | NHEK | skin |
18 | chr6:28190000-28190400 | Weak transcription | NHEK | skin |
19 | chr6:28190000-28192400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
20 | chr6:28190200-28192000 | Weak transcription | K562 | blood |
21 | chr6:28190400-28191000 | Enhancers | NHEK | skin |
22 | chr6:28190600-28190800 | Enhancers | HUVEC | blood vessel |
23 | chr6:28190800-28192200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
24 | chr6:28191000-28192000 | Weak transcription | NHEK | skin |
25 | chr6:28191000-28192200 | Weak transcription | HUVEC | blood vessel |
26 | chr6:28191200-28191400 | Bivalent/Poised TSS | H9 Cell Line | embryonic stem cell |
27 | chr6:28191200-28191400 | Enhancers | Placenta | Placenta |